Showing 501 - 520 results of 8,153 for search '"tumor"', query time: 0.09s Refine Results
  1. 501

    Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer by Kouji Banno, Miho Iida, Megumi Yanokura, Haruko Irie, Kenta Masuda, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki

    Published 2015-01-01
    “…New drugs for gynecologic tumors may be found by drug repositioning. For example, PPAR ligands may be effective against ovarian cancer, since PPAR activation eliminates COX-2 expression, arrests the cell cycle, and induces apoptosis. …”
    Get full text
    Article
  2. 502

    Ubiquitination of CD47 Regulates Innate Anti‐Tumor Immune Response by Qian Gou, Bingjun Yan, Yalan Duan, Yilei Guo, Jing Qian, Juanjuan Shi, Yongzhong Hou

    Published 2025-02-01
    “…Abstract In addition to adaptive immune checkpoint of PD‐1/PD‐L1, the innate immune checkpoint SIRPα/CD47 plays an important role in regulation of tumor immune escape. However, the mechanism of CD47 ubiquitination on tumor immune escape remains unclear. …”
    Get full text
    Article
  3. 503

    Federated Learning for Brain Tumor Diagnosis: Methods, Challenges and Future Prospects by Ma Yuhan

    Published 2025-01-01
    “…With the widespread application of Artificial Intelligence (AI) and Machine Learning (ML) in medical field, early diagnosis of brain tumors has become increasingly significant. However, traditional methods face challenges such as data privacy, model interpretability, and data heterogeneity. …”
    Get full text
    Article
  4. 504

    Chaos and bifurcation analysis of tumor-immune controlled system with time delay by Danni Wang, Hongli Yang, Liangui Yang

    Published 2025-04-01
    “…This paper establishes a delayed discrete tumor-immune model with feedback controller. The results indicate that the controlled system exhibits a trend from chaotic state to stability. …”
    Get full text
    Article
  5. 505
  6. 506

    Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma by Chun-Nan Yeh, Yu-Chan Chang, Yi-Chen Yeh, Yu-Chao Wang, Dennis Shin-Shian Hsu, Meng-Lun Lu, Michael Hsiao, Ming-Huang Chen, Nai-Jung Chiang, Shin-Yi Chung, Chien-Jung Huang, Ming-Hsien Chan, Tzu-Sheng Hsu, Yi-Ping Hung

    Published 2025-01-01
    “…Background Cholangiocarcinoma is a challenging malignancy with limited responses to conventional therapies, particularly immune checkpoint inhibitor therapy. Tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) are key components of the tumor microenvironment (TME) and have been implicated in the immune response to cancer. …”
    Get full text
    Article
  7. 507

    Tumor Location Correlates with Clinicopathological Features and Prognosis of the Solid Pseudopapillary Neoplasm by Zibo Meng, Mingsi Cao, Feiyang Wang, Yushun Zhang, Heshui Wu

    Published 2018-01-01
    “…We retrospectively evaluated 196 patients from our hospital and SEER database. We identified that tumor location was an independent prognostic indicator of SPN patients. …”
    Get full text
    Article
  8. 508

    Different DNA Loidy Patterns for the Differentiation of Common Subtypes of Renal Tumors by Guorong Li, Michèle Cottier, Odile Sabido, Anne Gentil-Perret, Claude Lambert, Christian Genin, Jacques Tostain

    Published 2005-01-01
    “…Objectives: The common subtypes of renal tumors are conventional or clear cell carcinoma, papillary carcinoma, chromophobe carcinoma and oncocytoma. …”
    Get full text
    Article
  9. 509

    Intravascular Glomus Tumor of the Forearm Causing Chronic Pain and Focal Tenderness by Sang Ki Lee, Dae Geon Song, Won Sik Choy

    Published 2014-01-01
    “…Introduction. A glomus tumor is a benign vascular tumor derived from glomus cells and occurs mainly in the subcutaneous layer of the subungual or digital pulp. …”
    Get full text
    Article
  10. 510
  11. 511
  12. 512

    The Fate of the Tumor in the Hands of Microenvironment: Role of TAMs and mTOR Pathway by Danilo Figueiredo Soave, Marina Pacheco Miguel, Fernanda Dias Tomé, Liliana Borges de Menezes, Patrícia Resende Alo Nagib, Mara Rúbia Nunes Celes

    Published 2016-01-01
    “…Since 2000, written with elegance and accuracy, Hanahan and Weinberg have proposed six major hallmarks of cancer and, together, they provide great advances to the understanding of tumoral biology. Our knowledge about tumor behavior has improved and the investigators have now recognized that inflammatory microenvironment may be a new feature for the tumor entities. …”
    Get full text
    Article
  13. 513

    Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison by Tania Fiaschi, Paola Chiarugi

    Published 2012-01-01
    “…Cancer cells are located in a very complex microenvironment together with stromal components that participate to enhance oxidative stress to promote tumor progression. Indeed, convincing experimental and clinical evidence underline the key role of oxidative stress in several tumor aspects thus affecting several characteristics of cancer cells. …”
    Get full text
    Article
  14. 514

    Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment by Christian Klein, Maria Amann, Jacob Gadwa, Laurel B Darragh, Miles Piper, Diemmy Nguyen, Sana D Karam, Michael W Knitz, Justin Yu, Nicholas Olimpo, Sophia Corbo, Jessica I Beynor, Brooke Neupert, Alexander T Nguyen, Chloe Hodgson, Khalid NM Abdelazeem, Anthony Saviola, Laurene Pousse, Ali Bransi, Mudita Pincha

    Published 2025-01-01
    “…Moreover, we show that through heterotopic implantations the site of tumor development defines the response to therapy, as implantation of HNSCC tumors into the pancreas resulted in comparable levels of tumor progression.Conclusions This work highlights the complexity of combining immunotherapies within the tumor microenvironment (TME) and further defines the immune and non-immune components of the TME as an intrinsic feature of immune suppression.…”
    Get full text
    Article
  15. 515

    Ovarian Mixed Malignant Brenner-Mucinous Tumor with Signet Ring Cells by Baharak Khadang, Atilla Omeroglu

    Published 2020-01-01
    “…., 2006, Young, 2006). Malignant Brenner tumor is also rare comprising less than 0.5% of ovarian carcinoma. …”
    Get full text
    Article
  16. 516
  17. 517
  18. 518

    Bilateral Ovarian Serous Borderline Tumor with Non-Invasive Endometrial Implants by Melissa Bou Malham, Jordy Mehawej, Andreas Filippaios, Christina Kushnir, Paulette Mhawech-Fauceglia

    Published 2023-01-01
    “…Microscopic evaluation showed findings consistent with left and right ovarian serous borderline tumor (SBT). Subsequently, a tumor staging was conducted with total laparoscopic hysterectomy, pelvic and periaortic lymph node dissection, and omentectomy. …”
    Get full text
    Article
  19. 519

    Recurrent Enlarging Mesenteric Desmoid Tumor following Remote Surgical Resection by Connie Hapgood, Allison DeLong

    Published 2017-01-01
    “…Intra-abdominal desmoid tumors are commonly associated with genetic syndromes such as familial polyposis coli. …”
    Get full text
    Article
  20. 520